top of page
  • cmargain

EMPIRI receives $500K

Excited and grateful that we received $500K from an angel investor, enabling us to move forward with our CLIA LDT certification and prototype testing for CAL, a first-in-class precision cancer diagnostic instrument.

Recent Posts

See All

Join Us at the 10x Genomics User Group Meeting!

We are excited to share that Kyuson Yun, co-founder of Empiri, will be presenting at the 10x Genomics User Group Meeting. This is a fantastic opportunity to learn about our high-quality, end-to-end si

Our store-front at

EMPIRI's E-slice 3D tumor culture platform for real-time evaluation of therapeutic candidates can now be accessed through our store-front at Scienist.Com for expedited study quoting and contracting.


bottom of page